WellellTPE:4106 +0.43%86 EBITDA Margin % is 10.57% as of Dec. 2025, which is 6% below its 10-year median of 11.25. GuruFocus rates TPE:4106 with a GF Score™ of 86/100 and a GF Value™ of NT$24.32 (Fairly Valued). The stock has 1 warning sign investors should review. Among 816 Medical Devices & Instruments companies, Wellell ranks better than 59.07% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Wellell's EBITDA for the
three
months ended in Dec. 2025 was NT$66 Mil. Wellell's Revenue for the
three
months ended in Dec. 2025 was NT$624 Mil. Therefore, Wellell's EBITDA margin for the quarter that ended in Dec. 2025 was 10.57%.
Wellell (TPE:4106) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Wellell EBITDA Margin % Related Terms
Wellell EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Wellell's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4106 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Wellell's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wellell EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Wellell's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Wellell's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wellell (TPE:4106) has a EBITDA Margin % of 10.57% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Wellell and its competitors. This is near median its historical median of 11.25. Over the past decade, Wellell's EBITDA Margin % has ranged from 10.08 to 13.07. According to the industry distribution chart, Wellell ranks #334 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 40.9%.
Is Wellell's EBITDA Margin % too high?
Wellell's current EBITDA Margin % of 10.57% is near median its 10-year median of 11.25. Over the past 10 years, this metric has ranged from a low of 10.08 to a high of 13.07. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Wellell's value of 10.57% is 41.4% above this industry median. Based on the distribution chart, Wellell ranks #334 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Wellell has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Wellell's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Wellell ranks #334 out of 816 companies for EBITDA Margin %. This puts Wellell in the upper half of its industry. The industry median EBITDA Margin % is 7.48. Wellell's value of 10.57% is 41.4% above this benchmark. Historically, Wellell's own EBITDA Margin % has ranged from 10.08 to 13.07 over the past decade. While the company's 10-year median is 11.25 vs. the industry median of 7.48, Wellell has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wellell's current EBITDA Margin % of 10.57% is 41.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Wellell and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wellell's current EBITDA Margin % is 10.57%, which is near median its own 10-year median of 11.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellell stock overvalued right now?
Based on GuruFocus' analysis, Wellell (TPE:4106) is currently considered Fairly Valued. The stock's GF Value™ is NT$24.32, compared to a current price of NT$23.20 — trading 4.6% below its estimated fair value. The current EBITDA Margin % is 10.57%, which is near median its 10-year median of 11.25 and 41.4% above the Medical Devices & Instruments industry median of 7.48. Wellell's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Wellell (TPE:4106), the current EBITDA Margin % is 10.57% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wellell (TPE:4106) Overvalued in 2026?
Based on GuruFocus' analysis, Wellell stock appears to be undervalued.
The current stock price of NT$23.20 is trading 4.6% below its estimated GF Value™ of NT$24.32.
GuruFocus considers Wellell to be Fairly Valued.
Key valuation signals for TPE:4106:
EBITDA Margin %: 10.57% (near median its 10-year median of 11.25)
GF Value™: NT$24.32 vs. price of NT$23.20 (4.6% below fair value)
Industry Position: 41.4% above the Medical Devices & Instruments median (#334 of 816)
No single metric tells the full story. See the TPE:4106 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wellell Inc engages in the manufacturing and sale of medical supplies, import and export, as well as agency services. The company provides medical solutions for post-acute care and acute care. Its products include pressure area care, support surfaces, respiratory therapy, compression therapy, and digital health. Geographically, the company operates in Europe, America, and Asia, and the majority of its revenue is generated from Europe.
86GF Score
Get the complete analysis for TPE:4106
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4106 has been successfully added to your 
